Related references
Note: Only part of the references are listed.Meningioma metastases: incidence and proposed screening paradigm
Cecilia L. Dalle Ore et al.
JOURNAL OF NEUROSURGERY (2020)
Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas
Mark W. Youngblood et al.
JOURNAL OF NEUROSURGERY (2020)
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis
Christian Mirian et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features
Erik A. Williams et al.
ACTA NEUROPATHOLOGICA (2020)
Recurrent IDH mutations in high-grade meningioma
Corey M. Gill et al.
NEURO-ONCOLOGY (2020)
Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment
Francesco Pepe et al.
HISTOLOGY AND HISTOPATHOLOGY (2020)
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
Nagarajan Paramasivam et al.
ACTA NEUROPATHOLOGICA (2019)
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients
Craig Horbinski et al.
NEURO-ONCOLOGY (2019)
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
Farshad Nassiri et al.
NEURO-ONCOLOGY (2019)
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
Leah M. Katz et al.
ACTA NEUROPATHOLOGICA (2018)
TERT Alterations in Progressive Treatment-Resistant Meningiomas
Tareq A. Juratli et al.
NEUROSURGERY (2018)
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
Tareq A. Juratli et al.
ACTA NEUROPATHOLOGICA (2018)
Progestin-associated shift of meningioma mutational landscape
M. Peyre et al.
ANNALS OF ONCOLOGY (2018)
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas
Ganesh M. Shankar et al.
NEURO-ONCOLOGY (2017)
Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas
Matthew R. Strickland et al.
JOURNAL OF NEUROSURGERY (2017)
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
Felix Sahm et al.
LANCET ONCOLOGY (2017)
BAP1 mutations in high-grade meningioma: implications for patient care
Ganesh M. Shankar et al.
NEURO-ONCOLOGY (2017)
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
Akdes Serin Harmanci et al.
NATURE COMMUNICATIONS (2017)
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
Tareq A. Juratli et al.
ONCOTARGET (2017)
Genomic landscape of high-grade meningiomas
Wenya Linda Bi et al.
NPJ GENOMIC MEDICINE (2017)
UpSetR: an R package for the visualization of intersecting sets and their properties
Jake R. Conway et al.
BIOINFORMATICS (2017)
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
Jie He et al.
BLOOD (2016)
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
Victoria E. Clarke et al.
NATURE GENETICS (2016)
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma
Malak Abedalthagafi et al.
NEURO-ONCOLOGY (2016)
The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer
Lili Liao et al.
CANCER GENETICS (2015)
ARID1A and TERT promoter mutations in dedifferentiated meningioma
Malak S. Abedalthagafi et al.
CANCER GENETICS (2015)
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia
Joni Van der Meulen et al.
BLOOD (2015)
High Incidence of Activating TERT Promoter Mutations in Meningiomas Undergoing Malignant Progression
Stephane Goutagny et al.
BRAIN PATHOLOGY (2014)
Molecular Pathways: Deregulation of Histone H3 Lysine 27 Methylation in Cancer-Different Paths, Same Destination
Teresa Ezponda et al.
CLINICAL CANCER RESEARCH (2014)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas
Miriam J. Smith et al.
NATURE GENETICS (2013)
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Priscilla K. Brastianos et al.
NATURE GENETICS (2013)
Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
Victoria E. Clark et al.
SCIENCE (2013)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2011)
NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions
D Lallemand et al.
GENES & DEVELOPMENT (2003)
Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas
T Joachim et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Alterations of the tumor suppressor genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in atypical and anaplastic meningiomas
J Boström et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)